KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Shares Outstanding (Weighted Average) (2016 - 2025)

Acadia Pharmaceuticals has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $168.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $168.4 million for Q4 2025, up 1.59% from a year ago — trailing twelve months through Dec 2025 was $168.4 million (up 1.59% YoY), and the annual figure for FY2025 was $168.4 million, up 1.59%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $168.4 million at Acadia Pharmaceuticals, roughly flat from $168.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for ACAD hit a ceiling of $168.8 million in Q3 2025 and a floor of $159651.0 in Q3 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $162.9 million (2023), compared with a mean of $115.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 99.9% in 2021 and later soared 101506.18% in 2025.
  • Acadia Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $160493.0 in 2021, then surged by 100641.47% to $161.7 million in 2022, then increased by 1.32% to $163.8 million in 2023, then grew by 1.16% to $165.7 million in 2024, then grew by 1.59% to $168.4 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $168.4 million (Q4 2025), $168.8 million (Q3 2025), and $167.8 million (Q2 2025) per Business Quant data.